FDA official says pandemic reauthorization bill could drive VALID across finish line

Regulatory NewsRegulatory NewsAfricaAPIsBiologics/ biosimilars/ vaccinesBiotechnologyCombination products/companion diagnosticsComplianceDiagnostics/IVDsEuropeMedical DevicesNorth AmericaNutritional/Natural HealthOTCOtherPharmaceuticalsRegulatory Intelligence/PolicySupply Chain Management